Gerri Henwood
2021 - Baudax Bio
In 2021, Gerri Henwood earned a total compensation of $1.7M as President and Chief Executive Officer at Baudax Bio, a 178% increase compared to previous year.
Compensation breakdown
| Option Awards | $89,836 |
|---|---|
| Salary | $618,000 |
| Stock Awards | $923,099 |
| Other | $43,535 |
| Total | $1,674,470 |
Henwood received $923.1K in stock awards, accounting for 55% of the total pay in 2021.
Henwood also received $89.8K in option awards, $618K in salary and $43.5K in other compensation.
Rankings
In 2021, Gerri Henwood's compensation ranked 6,771st out of 12,415 executives tracked by ExecPay. In other words, Henwood earned more than 45.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,771 out of 12,415 | 46th |
Division Services | 1,447 out of 2,290 | 37th |
Major group Health Services | 168 out of 252 | 33rd |
Industry group Miscellaneous Health And Allied Services, Not | 16 out of 32 | 50th |
Source: SEC filing on March 31, 2022.
Henwood's colleagues
We found one more compensation record of an executive who worked with Gerri Henwood at Baudax Bio in 2021.
2021
Richard Casten
Baudax Bio
Chief Financial Officer
News
Baudax Bio CEO Gerri Henwood's 2021 pay jumps 178% to $1.7M
March 31, 2022
Recro Pharma CFO Ryan Lake's 2020 pay jumps 161% to $2.2M
March 25, 2021
Baudax Bio CEO Gerri Henwood's 2020 pay falls 87% to $603K
March 11, 2021
Recro Pharma CEO Gerri Henwood's 2019 pay jumps 90% to $4.6M
March 27, 2020
Recro Pharma CEO Gerri Henwood's 2018 pay rises 16% to $2.4M
March 20, 2019